Kioi et al. [111] investigated the SDF-1/CXCR4 inhibitor AMD3100 and reported its superior efficacy over VEGF blockade in reducing tumor tissue perfusion after radiotherapy. This evidence concerns the gene CXCR4 and neoplasm.